These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9359552)

  • 21. [New anti-arrhythmia agents].
    Honerjäger P; Schmidt G
    Z Kardiol; 1992; 81 Suppl 4():133-7. PubMed ID: 1363260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Incalzi RA; Gemma A; Carbonin PU
    Lancet; 1997 Jun; 349(9067):1768; author reply 1769-70. PubMed ID: 9193399
    [No Abstract]   [Full Text] [Related]  

  • 23. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P
    Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 25. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Pinski SL
    Lancet; 1997 Jun; 349(9067):1768-9; author reply 1769-70. PubMed ID: 9193400
    [No Abstract]   [Full Text] [Related]  

  • 26. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Norris RM
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193396
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiarrhythmic drug therapy in patients with heart failure].
    Nakamura K; Nishii N; Ohe T
    Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
    [No Abstract]   [Full Text] [Related]  

  • 29. Limitations of present drug therapy of cardiac arrhythmias--a review.
    Jewitt DE
    Postgrad Med J; 1977; 53 Suppl 1():12-21. PubMed ID: 17855
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical therapy for arrhythmias and EBM].
    Otsuka T; Yamashita T
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):234-9. PubMed ID: 16536072
    [No Abstract]   [Full Text] [Related]  

  • 31. Crime, misdemeanor, and arrhythmia decoding CAST.
    Kerin NZ
    J Clin Pharmacol; 1991 Nov; 31(11):1044-52. PubMed ID: 1753008
    [No Abstract]   [Full Text] [Related]  

  • 32. Revisiting established medical options - antiarrhythmic drugs and beta-blocker combinations.
    Obel OA
    Resuscitation; 2000 Aug; 45(3):S7-S10. PubMed ID: 10959028
    [No Abstract]   [Full Text] [Related]  

  • 33. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
    Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
    Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
    Tsetskhladze E; Khintibidze I
    Georgian Med News; 2017 Jun; (267):53-57. PubMed ID: 28726654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fundamental principle in therapy for arrhythmia].
    Atarashi H
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):228-33. PubMed ID: 16536071
    [No Abstract]   [Full Text] [Related]  

  • 36. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
    Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J
    Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced proarrhythmic effects: assessment of changes in QT interval.
    Sheridan DJ
    Br J Clin Pharmacol; 2000 Oct; 50(4):297-302. PubMed ID: 11012551
    [No Abstract]   [Full Text] [Related]  

  • 38. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of arrhythmia in myocardial infarct (secondary prevention)].
    Gertsch M
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT).
    Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.